Eevia Health lands sales agreement for berry extracts with a minimum contract value of c. SEK 100 million
Eevia Health Plc, (”Eevia” or ”The Company”), a leading health ingredient manufacturer from Finland, today announces that it has entered a multi-year sales agreement for the US market with a key international customer.The agreement is for the supply of a standardized berry extract. The first three years of the sales agreement provides for a minimum contracted total sales of c. SEK 100 million. Eevia considers that there is a potential for extensions after three years. The minimum contract value may vary depending on raw material price fluctuations. The end customer is an internationally